Exome Asset Management’s RAPT Therapeutics RAPT Stock Holding History

Exome Asset Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,194	Closed	-$481K	–	76
2025 Q4	$481K	Buy	+14,194	New	+$441K	0.23%	57

Exome Asset Management's RAPT Position: Q1 2026 in Review

Exome Asset Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 14,194 shares — an estimated $481K sold.

Exome Asset Management first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $481K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Exome Asset Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Exome Asset Management sold 14,194 RAPT Therapeutics shares in Q1 2026, an estimated $481K.
Exome Asset Management first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
Exome Asset Management's RAPT Therapeutics position peaked at $481K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.